Lastly, similarly to miR-144, employed for the treatment of MDD [108], a fellow microRNA—miR-34c—was shown to inhibit the proliferation of human glioma by targeting PTP1B in severe combined immune deficiency (SCID) mice with xenografted tumors [165]. This evidence concerns the gene PTPN1 and major depressive disorder.